Antibodies, Monoclonal, Murine-Derived/*therapeutic use
Double-Blind Method
Humans
Immunologic Factors/*therapeutic use
Rituximab
*Severity of Illness Index
Sjogren's Syndrome/*drug therapy
Treatment Outcome
